PMGC Holdings Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 2.64 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.14M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company’s lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Details
| Name | PMGC Holdings Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 34 |
| Founded | 2020 |
| Ipo Date | 2023-11-21 |
| Ceo | Graydon Bensler |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 4.00 |
| Isin | US73017P6079 |
| Cusip | 73017P607 |
| Cik | 1840563 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Graydon Bensler C.F.A. | Chief Executive Officer, Chief Financial Officer, Secretary and Director |
Contact
| Address | 120 Newport Center Drive, Suite 249, Newport Beach, California 92660, United States |
| Phone | 866 445 4886 |
| Website | https://pmgcholdings.com |